195 related articles for article (PubMed ID: 37603792)
1. Elucidation of Secondary Structure and Toxicity of α-Synuclein Oligomers and Fibrils Grown in the Presence of Phosphatidylcholine and Phosphatidylserine.
Dou T; Matveyenka M; Kurouski D
ACS Chem Neurosci; 2023 Sep; 14(17):3183-3191. PubMed ID: 37603792
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of α-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation.
Dou T; Kurouski D
ACS Chem Neurosci; 2022 Aug; 13(16):2380-2385. PubMed ID: 35904551
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the Role of Lipids in the Aggregation of Amyloidogenic Proteins.
Kurouski D
Acc Chem Res; 2023 Nov; 56(21):2898-2906. PubMed ID: 37824095
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the Structural Organization of Individual α-Synuclein Oligomers Grown in the Presence of Phospholipids.
Dou T; Zhou L; Kurouski D
J Phys Chem Lett; 2021 May; 12(18):4407-4414. PubMed ID: 33945282
[TBL] [Abstract][Full Text] [Related]
5. The toxicities of A30P and A53T α-synuclein fibrils can be uniquely altered by the length and saturation of fatty acids in phosphatidylserine.
Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
J Biol Chem; 2023 Dec; 299(12):105383. PubMed ID: 37890776
[TBL] [Abstract][Full Text] [Related]
6. Phospholipids and Cholesterol Determine Molecular Mechanisms of Cytotoxicity of α-Synuclein Oligomers and Fibrils.
Zhaliazka K; Ali A; Kurouski D
ACS Chem Neurosci; 2024 Jan; 15(2):371-381. PubMed ID: 38166409
[TBL] [Abstract][Full Text] [Related]
7. Unsaturated fatty acids uniquely alter aggregation rate of α-synuclein and insulin and change the secondary structure and toxicity of amyloid aggregates formed in their presence.
Matveyenka M; Zhaliazka K; Kurouski D
FASEB J; 2023 Jul; 37(7):e22972. PubMed ID: 37302013
[TBL] [Abstract][Full Text] [Related]
8. Nanoscale imaging of individual amyloid aggregates extracted from brains of Alzheimer and Parkinson patients reveals presence of lipids in α-synuclein but not in amyloid β
Zhaliazka K; Kurouski D
Protein Sci; 2023 Apr; 32(4):e4598. PubMed ID: 36823759
[TBL] [Abstract][Full Text] [Related]
9. Macrophages and Natural Killers Degrade α-Synuclein Aggregates.
Matveyenka M; Zhaliazka K; Kurouski D
Mol Pharm; 2024 May; 21(5):2565-2576. PubMed ID: 38635186
[TBL] [Abstract][Full Text] [Related]
10. Lipids uniquely alter the secondary structure and toxicity of amyloid beta 1-42 aggregates.
Zhaliazka K; Matveyenka M; Kurouski D
FEBS J; 2023 Jun; 290(12):3203-3220. PubMed ID: 36705524
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.
O'Leary EI; Jiang Z; Strub MP; Lee JC
J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639
[TBL] [Abstract][Full Text] [Related]
12. Assembly of α-synuclein aggregates on phospholipid bilayers.
Lv Z; Hashemi M; Banerjee S; Zagorski K; Rochet JC; Lyubchenko YL
Biochim Biophys Acta Proteins Proteom; 2019 Sep; 1867(9):802-812. PubMed ID: 31226488
[TBL] [Abstract][Full Text] [Related]
13. Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates.
Matveyenka M; Zhaliazka K; Rizevsky S; Kurouski D
FASEB J; 2022 Oct; 36(10):e22543. PubMed ID: 36094052
[TBL] [Abstract][Full Text] [Related]
14. Length and saturation of choline plasmalogens alter the aggregation rate of α-synuclein but not the toxicity of amyloid fibrils.
Farid I; Ali A; Holman AP; Osborne L; Kurouski D
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130632. PubMed ID: 38447831
[TBL] [Abstract][Full Text] [Related]
15. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
[TBL] [Abstract][Full Text] [Related]
16. Membrane Interactions of α-Synuclein Probed by Neutrons and Photons.
Kaur U; Lee JC
Acc Chem Res; 2021 Jan; 54(2):302-310. PubMed ID: 33415971
[TBL] [Abstract][Full Text] [Related]
17. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
18. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis.
Ali A; Holman AP; Rodriguez A; Osborne L; Kurouski D
Neurobiol Dis; 2024 Aug; 198():106553. PubMed ID: 38839022
[TBL] [Abstract][Full Text] [Related]
20. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
